Resmed (RMD) Stock Price

$223 0.3%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    6

  • Fundamental

    10

  • Technical

    5

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Resmed, AI stock picks, stock alerts and much more.

Sign up

RMD AI Stock Analysis

AI stock analysis for RMD is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Resmed (RMD) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Resmed (RMD) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Resmed (RMD), currently trading at $223, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About RMD

LSE

  • ResMed Inc.

  • Symbol

    RMD

  • Market

    NYSE

  • Industry

    Medical - Instruments & Supplies

  • Market Cap

    32.8B

Similar Stocks

BDX Becton Dickinson and Co
BDX		 $226.4
0.2%
4
NVST Envista Holdings
NVST		 $17.51
2.4%
5
BAX Baxter International
BAX		 $33.65
1.1%
3
WST West Pharmaceutical Services
WST		 $221.5
0.6%
6
TFX Teleflex
TFX		 $141.4
0.8%
7

News

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025
April 2, 2025. globenewswire.com
Is it Worth Adding ResMed Stock to Your Portfolio Now?

Is it Worth Adding ResMed Stock to Your Portfolio Now?
March 7, 2025. zacks.com
ResMed Stock Climbs 25.6% in a Year: What's Driving the Rally?

ResMed Stock Climbs 25.6% in a Year: What's Driving the Rally?
March 5, 2025. zacks.com
Revisiting ResMed In 2025: Strong Q2 Financial Results And The Growing Demand For Sleep Apnea Solutions

Revisiting ResMed In 2025: Strong Q2 Financial Results And The Growing Demand For Sleep Apnea Solutions
February 10, 2025. seekingalpha.com

RMD Alternative Data

Web Traffic

Resmed receives an estimated 2.9M monthly visitors to resmed.com.

  • Web Traffic

    2892829

  • Change from Previous Month

    8.3%

  • 3 Month Change

    11.6%

  • YoY Change

    11.6%

News Mentions

Resmed was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    100%

  • 1 Month Change

    100%

  • 3 Month Change

    100%

Reddit Mentions

Resmed has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    100%

Twitter Followers

Resmed has 10,533 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.

  • Twitter Followers

    10533

  • Daily Change

    0%

  • 1 Month Change

    0.1%

  • 3 Month Change

    0.2%

  • YoY Change

    0.2%

Facebook Engagement

Resmed has engaged 1,424 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    1424

  • Daily Change

    0%

  • 1 Month Change

    9.6%

  • 3 Month Change

    987%

  • YoY Change

    987%

Instagram Followers

Resmed has 7,015 Instagram Followers on its main Instagram account, up by 8% over the last month.

  • Instagram Followers

    7015

  • Daily Change

    0.2%

  • 1 Month Change

    8%

  • 3 Month Change

    23%

  • YoY Change

    23%

Youtube Subscribers

Resmed has 49,700 subscribers on its main Youtube channel, up by 1.8% over the last month.

  • Youtube Subscribers

    49700

  • Daily Change

    0.2%

  • 1 Month Change

    1.8%

  • 3 Month Change

    5.1%

  • YoY Change

    5.1%

LinkedIn Followers

209,770 are following Resmed on LinkedIn, up by 2% over the last month.

  • LinkedIn Followers

    209770

  • Daily Change

    0.1%

  • 1 Month Change

    2%

  • 3 Month Change

    5.5%

Job Postings

Resmed currenly has an estimated 389 open job postings, up by 2.1% over the last month.

  • Job Postings

    389

  • Daily Change

    0.8%

  • 1 Month Change

    2.1%

  • 3 Month Change

    13.1%

  • YoY Change

    13.1%

LinkedIn Employees

According to LinkedIn, Resmed has 8,075 employees, up by 0.3% over the last month.

  • LinkedIn Employees

    8075

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    2.8%

  • YoY Change

    2.8%

Business Outlook

According to employee reviews, the business outlook among employees at Resmed is 73 out of 100 (bullish).

  • Business Outlook

    73

  • Change from Previous Month

    1.4%

  • 3 Month Change

    0%

  • YoY Change

    0%

App Downloads

  • App Downloads

    0

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

RMD Financials

RMD Key Metrics

  • Total Revenue

    $1.3B

  • Net Income

    $344.6M

  • Earnings per Share

    -$2.12

  • Free cash flow

    $289.7M

  • EBITDA

    $362.2M

  • EBITDA Ratio

    0.28249

  • Total Assets

    $7.1B

RMD 2-year Revenue & Income
RMD 2-year Free Cash Flow

RMD Technicals

RMD SMA
RMD RSI

FAQ

What's the current price of Resmed (RMD) Stock?
The price of an Resmed (RMD) share is $223.

What's the market cap of Resmed?
The current market cap of Resmed is 32.8B.

Should I buy or sell RMD?
Multiple alternative data signals suggest that Resmed stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.

Is Resmed a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Resmed stock. The bullish indicators suggest that Resmed's growth prospects and market position may lead to a positive performance in the foreseeable future.

Is now a good time to buy Resmed (RMD) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Resmed stock, given the bullish outlook.

What are some stocks similar to Resmed (RMD) that investors often compare it to?
Resmed (RMD) is often compared to similar stocks such as Becton Dickinson and Co, Envista Holdings, Baxter International, West Pharmaceutical Services and Teleflex.

What is the forecast for Resmed's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Resmed's stock price to be around $239.4 in 2026. Starting from the current price of $223, this represents a 7.4% change in price, indicating a bullish outlook for the stock.

How to buy Resmed (RMD) Stock?
Resmed stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Resmed shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.